| Lecanemab in early Alzheimer’s disease CH Van Dyck, CJ Swanson, P Aisen, RJ Bateman, C Chen, M Gee, ... New England Journal of Medicine 388 (1), 9-21, 2023 | 2879 | 2023 |
| Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's disease S Salloway, R Sperling, NC Fox, K Blennow, W Klunk, M Raskind, ... New England Journal of Medicine 370 (4), 322-333, 2014 | 2177 | 2014 |
| Classification and prediction of clinical Alzheimer's diagnosis based on plasma signaling proteins S Ray, M Britschgi, C Herbert, Y Takeda-Uchimura, A Boxer, K Blennow, ... Nature medicine 13 (11), 1359-1362, 2007 | 1323 | 2007 |
| Use of florbetapir-PET for imaging β-amyloid pathology CM Clark, JA Schneider, BJ Bedell, TG Beach, WB Bilker, MA Mintun, ... Jama 305 (3), 275-283, 2011 | 1250 | 2011 |
| Early role of vascular dysregulation on late-onset Alzheimer’s disease based on multifactorial data-driven analysis Y Iturria-Medina, RC Sotero, PJ Toussaint, JM Mateos-Pérez, AC Evans Nature communications 7 (1), 11934, 2016 | 1084 | 2016 |
| Multi-organ distribution of phosphorylated α-synuclein histopathology in subjects with Lewy body disorders TG Beach, CH Adler, LI Sue, L Vedders, LF Lue, CL White Iii, H Akiyama, ... Acta neuropathologica 119, 689-702, 2010 | 993 | 2010 |
| A phase 2 multiple ascending dose trial of bapineuzumab in mild to moderate Alzheimer disease S Salloway, R Sperling, S Gilman, NC Fox, K Blennow, M Raskind, ... Neurology 73 (24), 2061-2070, 2009 | 925 | 2009 |
| Cerebral PET with florbetapir compared with neuropathology at autopsy for detection of neuritic amyloid-β plaques: a prospective cohort study CM Clark, MJ Pontecorvo, TG Beach, BJ Bedell, RE Coleman, ... The Lancet Neurology 11 (8), 669-678, 2012 | 901 | 2012 |
| Clinical diagnosis of Alzheimer's disease: recommendations of the International Working Group B Dubois, N Villain, GB Frisoni, GD Rabinovici, M Sabbagh, S Cappa, ... The Lancet Neurology 20 (6), 484-496, 2021 | 778 | 2021 |
| Alzheimer's disease drug development pipeline: 2019 J Cummings, G Lee, A Ritter, M Sabbagh, K Zhong Alzheimer's & Dementia: Translational Research & Clinical Interventions 5 …, 2019 | 772 | 2019 |
| Why do trials for Alzheimer’s disease drugs keep failing? A discontinued drug perspective for 2010-2015 D Mehta, R Jackson, G Paul, J Shi, M Sabbagh Expert opinion on investigational drugs 26 (6), 735-739, 2017 | 700 | 2017 |
| Unified staging system for Lewy body disorders: correlation with nigrostriatal degeneration, cognitive impairment and motor dysfunction TG Beach, CH Adler, LF Lue, LI Sue, J Bachalakuri, J Henry-Watson, ... Acta neuropathologica 117, 613-634, 2009 | 679 | 2009 |
| Amyloid β peptide load is correlated with increased β-secretase activity in sporadic Alzheimer's disease patients R Li, K Lindholm, LB Yang, X Yue, M Citron, R Yan, T Beach, L Sue, ... Proceedings of the National Academy of Sciences 101 (10), 3632-3637, 2004 | 661 | 2004 |
| Longitudinal modeling of age-related memory decline and the APOE ε4 effect RJ Caselli, AC Dueck, D Osborne, MN Sabbagh, DJ Connor, GL Ahern, ... New England Journal of Medicine 361 (3), 255-263, 2009 | 618 | 2009 |
| Defining mild cognitive impairment in Parkinson's disease JN Caviness, E Driver‐Dunckley, DJ Connor, MN Sabbagh, JG Hentz, ... Movement disorders: official journal of the Movement Disorder Society 22 (9 …, 2007 | 604 | 2007 |
| Atorvastatin for the treatment of mild to moderate Alzheimer disease: preliminary results DL Sparks, MN Sabbagh, DJ Connor, J Lopez, LJ Launer, P Browne, ... Archives of neurology 62 (5), 753-757, 2005 | 585 | 2005 |
| New Acetylcholinesterase Inhibitors for Alzheimer′ s Disease M Mehta, A Adem, M Sabbagh International Journal of Alzheimer’s disease 2012 (1), 728983, 2012 | 577 | 2012 |
| Alzheimer's disease drug development pipeline: 2020 J Cummings, G Lee, A Ritter, M Sabbagh, K Zhong Alzheimer's & dementia: translational research & clinical interventions 6 (1 …, 2020 | 562 | 2020 |
| Low clinical diagnostic accuracy of early vs advanced Parkinson disease: clinicopathologic study CH Adler, TG Beach, JG Hentz, HA Shill, JN Caviness, E Driver-Dunckley, ... Neurology 83 (5), 406-412, 2014 | 544 | 2014 |
| Amyloid-related imaging abnormalities in patients with Alzheimer's disease treated with bapineuzumab: a retrospective analysis R Sperling, S Salloway, DJ Brooks, D Tampieri, J Barakos, NC Fox, ... The Lancet Neurology 11 (3), 241-249, 2012 | 543 | 2012 |
